Dello Russo, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 5.282
EU - Europa 4.207
AS - Asia 2.408
SA - Sud America 532
Continente sconosciuto - Info sul continente non disponibili 190
AF - Africa 69
OC - Oceania 11
Totale 12.699
Nazione #
US - Stati Uniti d'America 5.087
PL - Polonia 1.130
SG - Singapore 1.051
DE - Germania 835
IT - Italia 813
CN - Cina 543
BR - Brasile 414
SE - Svezia 357
VN - Vietnam 250
GB - Regno Unito 201
FR - Francia 195
UA - Ucraina 182
FI - Finlandia 122
IN - India 119
IE - Irlanda 97
CA - Canada 84
RU - Federazione Russa 79
ID - Indonesia 72
HK - Hong Kong 61
NL - Olanda 60
JP - Giappone 52
BD - Bangladesh 50
ES - Italia 39
MX - Messico 39
AR - Argentina 35
TR - Turchia 31
IL - Israele 24
IQ - Iraq 24
CL - Cile 23
BE - Belgio 22
AT - Austria 19
CO - Colombia 17
SA - Arabia Saudita 16
EC - Ecuador 15
KR - Corea 15
MA - Marocco 13
SC - Seychelles 13
ZA - Sudafrica 13
PK - Pakistan 12
AU - Australia 11
MY - Malesia 11
TT - Trinidad e Tobago 11
CZ - Repubblica Ceca 10
VE - Venezuela 10
IR - Iran 9
JM - Giamaica 9
CH - Svizzera 8
CR - Costa Rica 8
LT - Lituania 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
GT - Guatemala 7
UZ - Uzbekistan 7
BO - Bolivia 6
EG - Egitto 6
KE - Kenya 6
PH - Filippine 6
AL - Albania 5
BB - Barbados 5
HN - Honduras 5
JO - Giordania 5
NI - Nicaragua 5
PE - Perù 5
PR - Porto Rico 5
UY - Uruguay 5
AZ - Azerbaigian 4
KZ - Kazakistan 4
LB - Libano 4
PT - Portogallo 4
QA - Qatar 4
SV - El Salvador 4
BG - Bulgaria 3
CW - ???statistics.table.value.countryCode.CW??? 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
NP - Nepal 3
OM - Oman 3
AM - Armenia 2
BM - Bermuda 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GP - Guadalupe 2
KN - Saint Kitts e Nevis 2
MC - Monaco 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 12.497
Città #
Warsaw 1.114
Ashburn 706
Singapore 538
San Jose 428
Chandler 393
Fairfield 190
Houston 145
Jacksonville 138
Council Bluffs 131
Wilmington 118
Rome 116
Beijing 109
New York 105
Woodbridge 105
San Mateo 101
Dublin 97
Milan 96
Verona 95
Los Angeles 90
Seattle 87
Cambridge 84
Cattolica 82
Ann Arbor 79
Ho Chi Minh City 79
Munich 69
Helsinki 66
Nanjing 66
Dallas 62
Jakarta 60
The Dalles 59
Hanoi 58
Hong Kong 57
Lauterbourg 54
Hefei 52
São Paulo 51
Santa Clara 49
Bremen 48
Dearborn 46
Chicago 43
North Bergen 42
Phoenix 39
Tokyo 39
Lawrence 35
Nürnberg 34
Moscow 32
Boston 31
Frankfurt am Main 30
Buffalo 28
Redwood City 28
London 27
Nanchang 24
Philadelphia 24
Marseille 23
Nuremberg 23
Brooklyn 22
Lancaster 22
Manchester 22
St Louis 22
Atlanta 21
Boardman 20
Toronto 19
Brussels 18
Orem 18
Princeton 18
Denver 17
Mountain View 17
Shanghai 17
Lappeenranta 16
Da Nang 15
Montreal 15
Redmond 15
Charlotte 14
Hyderabad 14
Naples 14
Newark 14
Pune 14
Rio de Janeiro 14
San Francisco 14
Brasília 13
Kent 13
Paris 13
Chennai 12
Dong Ket 12
San Diego 12
Santiago 12
Guangzhou 11
Hangzhou 11
Izmir 11
Salvador 11
Washington 11
Düsseldorf 10
Falkenstein 10
Fremont 10
Jiaxing 10
Scottsdale 10
Seoul 10
Shenyang 10
Sydney 10
Baghdad 9
Las Vegas 9
Totale 7.177
Nome #
The human microglial HMC3 cell line: where do we stand? A systematic literature review 528
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 526
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 451
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 440
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 439
mTOR kinase: a possible pharmacological target in the management of chronic pain 429
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 396
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 384
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 376
Effects of remifentanil on human C20 microglial pro-inflammatory activation 303
Antiretrovirals inhibit arginase in human microglia 230
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 227
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 224
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 213
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 209
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 196
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 190
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 186
Antiretrovirals inhibit arginase in human microglia 182
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study 180
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 178
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 174
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 171
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 166
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 163
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 163
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 160
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 159
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 158
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception 158
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 156
Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer 156
Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature 156
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 155
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 155
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 153
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 152
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 147
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 147
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES 142
Exploiting microglial functions for the treatment of glioblastoma 140
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 139
Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature 139
LAT1, a novel pharmacological target for the treatment of glioblastoma 138
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 136
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 136
The Future of Personalized Medicine in Space: From Observations to Countermeasures 134
Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target 134
The role of sevoflurane exposure on systemic inflammation and neuroinflammation: a systematic review and meta-analysis of in vivo and in vitro studies 132
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testing 132
Perioperative analgesia in the elderly 131
Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy 131
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function 129
What is the weight of expectation bias in oncology trials? 126
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 126
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia 123
Relationship between blood remifentanil concentration and stress hormone levels during pneumoperitoneum in patients undergoing laparoscopic cholecystectomy 123
Exploiting Microglial Functions for the Treatment of Glioblastoma 121
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Uncontrolled Oncology Trials: A Comprehensive Review of the Literature 116
Recovery from deep neuromuscular blockade using different sugammadex doses in elderly patients undergoing laparoscopic robot-assisted prostatectomy 114
UGT1A1 and Sacituzumab Govitecan Toxicity: A Systematic Review and Meta‐Analysis 87
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx) 85
Main factors associated with variability in the assessment of the objective response rate. A re-analysis of the PHEREXA phase 3 clinical trial 75
HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) 50
Ri-Medi: a pilot implementation of a medication review and deprescribing service in primary care for elderly patients with polypharmacy in Rome 34
FMR1 RNA int er action with DNMT1 blocks DNA methylation at the FMR1 locus 33
UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics 33
ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) 31
Clopidogrel versus aspirin for coronary artery disease 30
MT-RNR1 genotype testing for preventing aminoglycoside-mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) 30
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx) 24
Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature 20
Interleukin-1 in the central nervous system: from physiology to pathology. 17
Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro. Evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase. 15
Erytropoietin exerts its anti-apoptotic effects on rat microglial cells in vitro. 13
Circulating interleukin-1b levels after acute and prolonged exposure to low temperatures. Human and rat studies. 11
Nociceptin (1-13)NH2 inhibits stimulated calcitonin-gene-related-peptide release from primary cultures of rat trigeminal ganglia neurones 10
HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase 9
Primary cultures of microglial cells for testing toxicity of anticancer drugs. 8
A functional link between heme oxygenase and cyclo-oxygenase activities in cortical rat astrocytes. 6
Totale 12.699
Categoria #
all - tutte 44.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022514 0 0 0 0 55 17 24 79 21 44 170 104
2022/20231.164 138 139 75 166 107 118 40 116 164 30 43 28
2023/2024750 42 149 33 86 40 101 72 21 9 38 73 86
2024/20251.322 29 37 95 45 104 81 37 62 243 121 255 213
2025/20263.656 451 105 220 421 525 204 628 175 277 290 169 191
2026/20271.493 167 151 287 700 188 0 0 0 0 0 0 0
Totale 12.699